Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs . But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupt
Novel molecules fight viruses by bursting their bubble-like membranes
